Universe Pharmaceuticals Inc
4 hedge funds and large institutions have $33.7K invested in Universe Pharmaceuticals Inc in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 2 → 4 (+2)
0% more ownership
Funds ownership: 0% → 0% (+0%)
16% less capital invested
Capital invested by funds: $40K → $33.7K (-$6.35K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$10.8K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$10.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$4.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Acadian Asset Management
Boston,
Massachusetts
| $12K | – | – | – |
|
|
2
Renaissance Technologies
New York
| $9K | -$4.3K | -2 | -22% |
|
|
TSS
3
Two Sigma Securities
New York
| $6.65K | +$10.8K | +5 | New |
|
|
HF
4
HRT Financial
New York
| $6K | +$10.8K | +5 | New |
|
UPC Hedge Fund Activity: Q2 2023 in Review
4 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Universe Pharmaceuticals Inc (UPC) for Q2 2023, worth a combined $33.7K — down 16% from $40K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new UPC positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $10.8K. The largest seller was Renaissance Technologies, cutting an estimated $4.3K.
- 4 institutional investors held Universe Pharmaceuticals Inc (UPC) as of Q2 2023, up from 2 in Q1 2023.
- Funds reported $33.7K of Universe Pharmaceuticals Inc stock for Q2 2023, down 16% quarter-over-quarter.
- 2 funds opened new Universe Pharmaceuticals Inc positions in Q2 2023 and 0 closed out, a net change of +2 holders.
- The largest Universe Pharmaceuticals Inc buyer in Q2 2023 was HRT Financial, an estimated $10.8K added.
- The largest Universe Pharmaceuticals Inc seller in Q2 2023 was Renaissance Technologies, an estimated $4.3K sold.
Based on aggregated 13F filings for Q2 2023.